Lonza Group AG (SWX: LONN)

Market Cap	37.34B
Revenue (ttm)	6.70B
Net Income (ttm)	573.00M
Shares Out	72.23M
EPS (ttm)	7.92
PE Ratio	65.26
Forward PE	33.67
Dividend	4.00 (0.78%)
Ex-Dividend Date	n/a

Volume	111,510
Open	522.00
Previous Close	513.60
Day's Range	514.80 - 522.60
52-Week Range	315.60 - 589.40
Beta	0.65
Analysts	n/a
Price Target	n/a
Earnings Date	Jan 29, 2025

About Lonza Group AG

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substanc...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1897
• Employees: 18,000
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: LONN

Financial Performance

In 2023, Lonza Group AG's revenue was 6.72 billion, an increase of 7.94% compared to the previous year's 6.22 billion. Earnings were 654.00 million, a decrease of -46.17%.